{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:10:29Z","timestamp":1790111429832,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejpb.2026.115155","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:58:33Z","timestamp":1781798313000},"page":"115155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and validation of a poly-L-lysine dendrimer-based rapamycin delivery system for intracranial drug-coated balloons"],"prefix":"10.1016","volume":"226","author":[{"given":"Jiaping","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7619-9560","authenticated-orcid":false,"given":"Haipo","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejpb.2026.115155_b0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5853\/jos.2014.16.3.105","article-title":"Research on intracranial atherosclerosis from the East and west: why are the results diferent?","volume":"16","author":"Kim","year":"2014","journal-title":"J Stroke"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115155_b0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1212\/WNL.55.4.490","article-title":"Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy","volume":"55","author":"Thijs","year":"2000","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115155_b0015","first-page":"1033","article-title":"Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study","volume":"52","author":"Qureshi","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejpb.2026.115155_b0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jocn.2018.10.118","article-title":"Efcacy and safety of drugeluting stent for the intracranial atherosclerotic disease: a systematic review and meta-analysis","volume":"59","author":"Ye","year":"2019","journal-title":"J. Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115155_b0025","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.STR.0000128708.86762.d6","article-title":"Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results","volume":"35","author":"Investigators","year":"2004","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115155_b0030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1253\/circj.CJ-09-0059","article-title":"Molecular basis of restenosis and novel issues of drugeluting stents","volume":"73","author":"Inoue","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.ejpb.2026.115155_b0035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2026.115155_b0040","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejpb.2026.115155_b0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ejpb.2026.115155_b0050","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/eurheartj\/ehv204","article-title":"Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document","volume":"37","author":"Cortese","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejpb.2026.115155_b0055","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"355","author":"Scheller","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2026.115155_b0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcin.2012.01.008","article-title":"Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"5","author":"Scheller","year":"2012","journal-title":"J. Am. Coll. Cardiol. Intv."},{"key":"10.1016\/j.ejpb.2026.115155_b0065","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis","volume":"119","author":"Unverdorben","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejpb.2026.115155_b0070","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","article-title":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study","volume":"59","author":"Rittger","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejpb.2026.115155_b0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcin.2010.10.012","article-title":"Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis","volume":"4","author":"Habara","year":"2011","journal-title":"J. Am. Coll. Cardiol. Intv."},{"key":"10.1016\/j.ejpb.2026.115155_b0080","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxeleluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISARDESIRE 3): a randomised, open-label trial","volume":"381","author":"Byrne","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115155_b0085","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jvir.2016.06.036","article-title":"Comparison of particulate embolization after femoral artery treatment with IN. PACT Admiral versus Lutonix 035 paclitaxel-coated balloons in healthy swine","volume":"27","author":"Kolodgie","year":"2016","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ejpb.2026.115155_b0090","series-title":"Methods in Cell Biology","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.mcb.2018.03.040","article-title":"Dissecting the role of the tubulin code in mitosis","author":"Ferreira","year":"2018"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115155_b0095","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0735-1097(00)00614-8","article-title":"Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo","volume":"35","author":"Herdeg","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115155_b0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/1526602820941811","article-title":"Six-month outcomes from the first-in-human, single-arm SELUTION sustained-limus-release drug-eluting balloon trial in femoropopliteal lesions","volume":"27","author":"Zeller","year":"2020","journal-title":"J. Endovasc. Ther."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115155_b0105","first-page":"427","article-title":"Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology","volume":"83","author":"Cortese","year":"2014","journal-title":"Catheter Cardio. Int."},{"issue":"1\u20133","key":"10.1016\/j.ejpb.2026.115155_b0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2005.09.042","article-title":"Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries","volume":"524","author":"Parry","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"9616","key":"10.1016\/j.ejpb.2026.115155_b0115","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","article-title":"A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial","volume":"371","author":"Ormiston","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115155_b0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1163\/138577210X509552","article-title":"Dendrimers in drug-delivery applications","volume":"13","author":"Lin","year":"2010","journal-title":"Des. Monomers Polym."},{"issue":"26","key":"10.1016\/j.ejpb.2026.115155_b0125","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1039\/C4TB00171K","article-title":"Dendrimers for drug delivery","volume":"2","author":"Caminade","year":"2014","journal-title":"J. Mater. Chem. B"},{"issue":"13","key":"10.1016\/j.ejpb.2026.115155_b0130","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3390\/nu15132873","article-title":"Glycocalyx-Sodium Interaction in Vascular Endothelium","volume":"15","author":"Sembajwe","year":"2023","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115155_b0135","doi-asserted-by":"crossref","first-page":"18794","DOI":"10.1021\/acsnano.1c07121","article-title":"Multiscale shellac-based delivery systems: from macro-to nanoscale","volume":"15","author":"Yuan","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2026.115155_b0140","unstructured":"Stankus J, Trollsas M, Hossainy S. Coatings with tunable solubility profile for drug-coated balloon: U.S. Patent 8,480,620. 2013-7-9."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115155_b0145","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3390\/molecules25071596","article-title":"Pre-clinical investigation of keratose as an excipient of drug coated balloons","volume":"25","author":"Goel","year":"2020","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115155_b0150","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/acs.jpcb.7b11928","article-title":"Unique features of metformin: a combined experimental, theoretical, and simulation study of its structure, dynamics, and interaction energetics with DNA grooves","volume":"122","author":"Mondal","year":"2018","journal-title":"J. Phys. Chem. B"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115155_b0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115155_b0160","first-page":"198","article-title":"Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems","volume":"47","author":"Perkins","year":"2010","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ejpb.2026.115155_b0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2020.12.071","article-title":"Efficacy and safety of a magnesium stearate paclitaxel coated balloon catheter in the porcine coronary model","volume":"331","author":"Bettink","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115155_b0170","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/ATVBAHA.107.156281","article-title":"Intramural delivery of rapamycin with \u03b1v\u03b23-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury","volume":"28","author":"Cyrus","year":"2008","journal-title":"Arterioscl Throm Vas."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115155_b0175","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1039\/C4BM00351A","article-title":"Recent advances in targeted drug delivery approaches using dendritic polymers","volume":"3","author":"Bugno","year":"2015","journal-title":"Biomater. Sci.-UK"},{"key":"10.1016\/j.ejpb.2026.115155_b0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13036-022-00298-5","article-title":"Dendrimer-based drug delivery systems: history, challenges, and latest developments","volume":"16","author":"Wang","year":"2022","journal-title":"J. Biol. Eng."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115155_b0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.RES.76.3.412","article-title":"Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells","volume":"76","author":"Marx","year":"1995","journal-title":"Circ. Res."},{"issue":"16","key":"10.1016\/j.ejpb.2026.115155_b0190","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/CIRCULATIONAHA.119.041099","article-title":"Paclitaxel-coated balloons and eluting stents: is there a mortality risk in patients with peripheral artery disease?","volume":"140","author":"Beckman","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejpb.2026.115155_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.947776","article-title":"The factors influencing the efficiency of drug-coated balloons","volume":"9","author":"Cao","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115155_b0200","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1172\/JCI119038","article-title":"Rapamycin inhibits vascular smooth muscle cell migration","volume":"98","author":"Poon","year":"1996","journal-title":"J. Clin. Invest."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:45:21Z","timestamp":1790109921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"alternative-id":["S0939641126001761"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115155","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and validation of a poly-L-lysine dendrimer-based rapamycin delivery system for intracranial drug-coated balloons","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115155"}}